Detalles de la búsqueda
1.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
J Cancer Res Clin Oncol;
150(4): 189, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38605258
2.
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
Sci Bull (Beijing);
68(18): 2106-2114, 2023 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599175
3.
[Efficacy of Tyrosine Kinase Inhibitor Combined with Decitabine, Homoharringtonine, Interferon in the Maintenance Therapy of Blast Phase Chronic Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
31(3): 649-653, 2023 Jun.
Artículo
en Chino
| MEDLINE | ID: mdl-37356921
4.
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.
Blood Adv;
7(16): 4349-4357, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078706
5.
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.
Transplant Cell Ther;
29(2): 136.e1-136.e7, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402457
6.
Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.
EClinicalMedicine;
52: 101682, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313145
7.
[Bioinformatics Analysis of Microarray Data in Myelodysplastic Syndrome Based on Gene Expression Omnibus Database].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
30(2): 511-515, 2022 Apr.
Artículo
en Chino
| MEDLINE | ID: mdl-35395988
8.
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial.
Clin Transl Med;
11(9): e539, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34586746
9.
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
J Hematol Oncol;
14(1): 145, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526099
10.
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Bone Marrow Transplant;
56(12): 2940-2947, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433917
11.
Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma.
Leukemia;
35(10): 3002-3006, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031533
12.
[PX-12 Promoting Apoptosis of Multiple Myeloma Cell Line H929 Induced by Bortezomib].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
29(2): 515-519, 2021 Apr.
Artículo
en Chino
| MEDLINE | ID: mdl-33812423
13.
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant.
Leukemia;
35(6): 1563-1570, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077866
14.
[Research Advance of Venetoclax in Hematological Tumors--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi;
28(4): 1419-1423, 2020 Aug.
Artículo
en Chino
| MEDLINE | ID: mdl-32798437
15.
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
J Clin Oncol;
38(29): 3367-3376, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32650683
16.
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
Genome Med;
12(1): 41, 2020 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349779
17.
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients.
Eur J Haematol;
105(3): 326-334, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32421883
18.
Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.
Cancer Immunol Immunother;
69(8): 1493-1504, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285170
19.
Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods.
Cancer Manag Res;
11: 8295-8302, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571987
20.
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
Lancet Haematol;
6(6): e328-e337, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31126528